Qiming Granule Targets Gut-Retina Axis to Attenuate Diabetic Chorioretinopathy
Diabetic chorioretinopathy (DCR) is a severe complication of diabetes that can lead to vision loss, yet current treatments struggle to stop its progression. Recent research suggests that the "gut-retina axis", a two-way communication system involving gut bacteria, their metabolites, plays a key role in DCR development.Qiming Granule (QMG), a traditional Chinese medicine, has shown promise in treating diabetic eye disease, but how it interacts with the gut-retina axis remains unknown.Study Goal: To explore gut microbiota changes in diabetic chorioretinopathy mice treated with Qiming Granule (QMG), a traditional Chinese formula for diabetic eye complications.Relevance: This dataset presents preliminary 16S rDNA sequencing results of gut microbiota changes mediated by Qiming Granule (QMG), offering a foundational reference for understanding traditional Chinese medicine's role in regulating the diabetic gut-retina axis.